Chromatography
New Chromabond® Drug Ii
May 15 2007
CHROMABOND® Drug II contains a bifunctional adsorbent material, consisting from a strong anion exchanger (SAX, quaternary amine) and C8 modified silica. Two primary retention mechanisms facilitate the use of very strong interferant eluting solvents resulting in very pure extracts especially from heavily matrix loaded samples like urine, plasma, serum or whole blood.
Already available from Macaherey Nagel is CHROMABOND® Drug a SPE-cartridge for enrichment of acidic, neutral and basic drugs. By introducing CHROMABOND® Drug II the scope of SPE products for drug analysis is widened by the important group of THCs.
Digital Edition
ILM 50.3 April 2025
May 2025
Chromatography Articles - Optimising two-step purification: Key considerations for sample pump setups Mass Spectrometry & Spectroscopy Articles - Detecting pharmaceuticals and their transf...
View all digital editions
Events
May 18 2025 Brussels, Belgium
InformEx Zone at CPhl North America
May 20 2025 Philadelphia, PA, USA
May 21 2025 Birmingham, UK
May 27 2025 Basel, Switzerland
Jun 01 2025 Baltimore, MD, USA